Navigation path

Pharmaceuticals - Community Register


Community list of not active orphan medicinal products


Product information

Deferoxamine mesilate

EU orphan designation number: EU/3/04/231
Active ingredient: Deferoxamine mesilate
Indication: Treatment of traumatic spinal cord injury
Sponsor: SCT Spinal Cord Therapeutics GmbH
Max-Planck-Straße 15a, 40699 Erkrath, Deutschland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
25/10/2004 Orphan designation EMEA/OD/014/04 (2004)4197 of 20/10/2004
16/05/2006 Change of name and/or address of sponsor
05/06/2009 Change of name and/or address of sponsor
28/02/2013 Removal of orphan designation from Community Register